Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched the t:slim X2 insulin pump with the Abbott FreeStyle ...

Trinity Biotech (Nasdaq:TRIB) today announced new clinical findings supporting its next-generation continuous glucose monitor ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

West Pharmaceutical Services (NYSE:WST) announced that it completed the sale of its SmartDose on-body delivery system to ...

ALR Technologies announced today that it entered into a letter of intent to acquire equity and assets of CGM Medical ...

BD (NYSE:BDX) announced today that it appointed Matthew Sassone as worldwide president of its Pharmacy Automation business.

NanoPortal technology held in the hand [Image courtesy of Vivani] Vivani Medical (Nasdaq:VANI) today announced a new agreement with Novo Nordisk to evaluate the NPM-139 long-term semaglutide implant.

The Omnipod 5 with an iPhone [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 insulin pump and Omnipod Discover platform in Spain. With the launch, ...

Glucotrack (Nasdaq:GCTK) announced today that it secured new intellectual property allowance protecting its continuous blood glucose monitor (CBGM). The patent application, titled “Methods and Systems ...